Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 2/3 1Phase 1/2 1

Status

Completed 4Terminated 1

Sponsor Class

OTHER 2INDUSTRY 2NETWORK 1

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 5

Conditions

Breast Neoplasms 167Neoplasm Metastasis 18Breast Neoplasms, Male 15Neoplasms 13Brain Neoplasms 11Inflammatory Breast Neoplasms 5Triple Negative Breast Neoplasms 2Stomach Neoplasms 2Ovarian Neoplasms 2Osteitis Deformans 2Lung Neoplasms 2HER2 Positive Metastatic Breast Cancer 2Esophageal Neoplasms 2Carcinoma, Ovarian Epithelial 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Intraductal, Noninfiltrating 2Carcinoma, Ductal, Breast 2Breast Diseases 2Urinary Bladder Neoplasms 1Prostatic Neoplasms 1Patient Compliance 1Neoplastic Cells, Circulating 1Metastatic Breast Cancer With Intracranial Metastases 1Invasive Breast Cancer 1Insulin-Like Growth Factor I, Resistance To 1Her2 Positive Metastatic Breast Cancer 1HER2-positive Advanced Breast Cancer 1HER2-Positive Early Stage Breast Cancer 1HER2+ Metastatic Breast Cancer (MBC) 1HER2 Positive Breast Cancer 1

Interventions

Cyclophosphamide 38Paclitaxel 22Epirubicin 21Trastuzumab 20Docetaxel 20Doxorubicin 19Carboplatin 15Radiotherapy 13Taxes 11Filgrastim 11Neoadjuvant Therapy 9Bevacizumab 9Fluorouracil 8pembrolizumab 7Tamoxifen 7Albumin-Bound Paclitaxel 7Capecitabine 6pertuzumab 5Thiotepa 5Peripheral Blood Stem Cell Transplantation 5Lapatinib 5130-nm albumin-bound paclitaxel 5pegfilgrastim 4Granulocyte Colony-Stimulating Factor 4Cisplatin 4Chemotherapy, Adjuvant 4Biopsy 4tipifarnib 3eribulin 3Surgical Procedures, Operative 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Inflammatory Breast Neoplasms × Lapatinib × Breast × Clear all
NCT00450892 2016-07-07

Phase I/II Study of Neoadjuvant Lapatinib in Breast Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 1/2 Completed
129 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT01426880 2016-02-15

GeparSixto

GBG Forschungs GmbH

Phase 2/3 Completed
595 enrolled
Breast

Carcinoma, Ductal, Breast, Inflammatory Breast Neoplasms

NCT00105950 2015-09-28

Study Of Lapatinib In Patients With Relapsed Or Refractory Inflammatory Breast Cancer

GlaxoSmithKline

Phase 2 Completed
126 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00756470 2014-11-17

Phase II Neoadjuvant in Inflammatory Breast Cancer

M.D. Anderson Cancer Center

Phase 2 Terminated
15 enrolled 10 charts
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00558103 2013-02-04

Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Inflammatory Breast Cancer

GlaxoSmithKline

Phase 2 Completed
163 enrolled 14 charts
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡